Morisawa, Norihiko <br/><br/>
Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease.  [electronic resource] 

 -  Clinical and experimental nephrology  Oct 2017 
 - 818-824 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1437-7799 
<br/><br/><label>Standard No.: </label>10.1007/s10157-016-1348-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--adverse effects<br/>Carbamates<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Glomerular Filtration Rate<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Imidazoles--adverse effects<br/>Isoquinolines--adverse effects<br/>Japan<br/>Kidney--physiopathology<br/>Longitudinal Studies<br/>Male<br/>Pyrrolidines<br/>RNA, Viral--blood<br/>Renal Insufficiency, Chronic--complications<br/>Retrospective Studies<br/>Sulfonamides--adverse effects<br/>Sustained Virologic Response<br/>Time Factors<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Viral Load